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The aim of the present study was to extend our previous 
hypothesis that the inflammatory reaction in psoriasis is neu-
rogenic, and that substance P mediates the inflammation. 
For this purpose, the pattern of neurofilamcnt-positive sen-
sory nerve fibers was studied and the lengths and substance P 
content of these fibers measured morphometrically in dermal 
and epidermal compartments of the psoriatic lesion, psoriatic 
but lesion-free skin. and control skin. 
The epidermis and dermis of the psoriatic lesions were 
significantly more densely innervated with neurofilament-
posi tive fibers than either lesion-free psoriatic or control 
skin. Although substance P is known to be rapidly degraded 
Psoriasis is a disorder of the total skin appearing in patients genetically predisposed to this disease [1]. Histologi-cally, psoriatic lesions are characterized by hyperplasia and altered differentiation of the epidermis. dilated cap-illaries in the r.apillary dennis. and inflammation in both 
dermis and epidermis [2 . The disease is known to have exacerba-
tions and remissions affected by general changes occurrin~ in the 
body, e.g., hormonal changes at puberty and menopause l3J, and 
various forms of stress [4,5]. This suggests the involvement of 
neural-derived factors in the pathogenesis of psoriatic lesions. The 
symmetrical appearance of the lesions further suppOrtS this view [5]. 
When the role of the nervous system in inflammatory responses was 
studied, substance P (SP) was the first neuropeptide transmitter 
identified and purified. SP is synthesized in the dorsal root ganglia 
and transported to peripheral sensory nerve endings where it is 
released by various stimuli [6]. The skin is richly innervated with 
unmyelinated sensory fibers, and SP has been localized in the free 
nerve endin~s in the dermal papillae and epidermis of healthy 
~uman s~in l7.'8]. SP is the only effective neuroreptide shown to 
Induce hIstamine release from rat mast cells [9 . Cooperation of 
histamine and SP is suggested to result in the axOJl reflex, i.e., 
activation of sensory nerves leads to peripheral release ofSP, which 
in turn releases histamine from mast cells. and the released hista-
mine further excites other sensory neurons [1 OJ. In an early psoriatic 
lesion, one of the first morphologic changes observed by some in-
vestigators is the dcgranuiating mast cell [t 1-13]. Mast cells are 
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in tissues, and its accual concentrations in the sections were 
unknown, there was an increase in substance P containing 
nerves in the psoriatic lesion. the increase being significant in 
the epidermal nerve fibers. No significant differences in the 
measured parameters were obtained between lesion-free 
psoriatic and control skin. 
These results indicate that there is an altered pattern of 
sensory nerves in a psoriatic plaque and that substance P may 
be an important mediator in the inflammatory processes that 
contribute either to the initiation or maintenance of a psoria-
tic lesion.] 111l1est DerlllatoI92:126-129, 1989 
also more frequent in psoriatic lesions than in normal skin (14}. 
Thus, c1emems for neurogenic inflammation seem to exist in a 
psoriatic lesion. In fact, abnormality and increased turnover of cuta-
neous nerves in psoriasis has been previously reported by Weddell et 
.1 [15J. 
The aim of the present study was to find out if the innervation 
pattern and the contenc of SP in the cutaneous nerves are altered in 
psoriatic skin. For this, sections from psoriatic lesions, lesion-free 
psoriatic, and control skin biopsies were stained immunohisto-
chemically and the nerve lengths measured morphometrically. 
MATERlAL AND METHODS 
Biopsies Punch biopsies of 3 to 4 mrn were taken from lesional 
skin of 15 psoriatic patiencs, lesion-free skin of seven psoriatic pa-
tients, and concrol skin of nine persons. All the psoriatic patients 
were adults representing both sexes and different age groups. The 
psoriatic biopsies were at different stages from non-digital skin. 
Psoriatic, but lesion-free skin was taken at least 2 cm in distance 
from a lesion. One lesional and one lesion-free biopsy were raken 
from the same psoriatic patient. Otherwise all the biopsies studied 
were from different patients. Control skin was received from face 
lift operations, all the donors being female (54.7 ± 4.6 years, M ± 
SEM). Because site-matched biopsy material from healthy concrols 
was not available, the face-lift skin was used because it has a rich 
neurovascular supply. After removal, the biopsies were immediately 
immersed in saline, and within a few hours embedded in OCT 
Compound (Miles Scientific, Naperville. IL) and frozen in liquid 
nitrogen. The frozen biopsies were stored in -70°C umil further 
processed. 
Immunohistochemical Stains For immunohistochemical 
staining, 16.um cryosections were cut and placed on poly-L-Iysine 
(Sigma Chemical Co., Sf Louis, MO) coated slides. Serial sections 
from the same biopsy were stained with both the polyclonal rabbit 
antihuman neurofilament (NF) antibody (gift from Dr. Dahl, West 
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Roxbury Veterans Administration Medical Center, Boston, MA). 
and [he polyclonal rabbit anti-human substance P (SP) antibody 
(Histo-Tek Antisera, Miles Scientific). The anti-NF antibody was 
raised in rabbits against degraded anrigen from phosphate buffer 
extracts of autolyzed human spinal cord as discussed by Dahl and 
Dignami [16]. This antiserum has been previously characterized in 
identification of sensory nerves in human skin [171. The stainings 
were carried out at room temperature. After a 10 min treatment 
with normal goae serum, both antisera were used as a 1 : 1,000 dilu-
tion on sections for 60 min. After a thorough rinse with phosphate-
buffered saline (PBS) a biotinylated goat anti-rabbit IgG (Vectastain 
ABC kit, PK-4001, Vector Laboratories, Burlingame, CA) was ap-
plied on the sections for 30 min. After PBS rinses and a 5 min 
hydrogen peroxide treatment an avidin-biotin-peroxidasc complex 
(Vectastain ABC kit, PK-4001) was added on the sections for 40 
min, followed by PBS rinses. The peroxidase enzyme was visualized 
by incubating the sections in 0.05% 3.3' -diaminobenzidine tetrahy-
drochloride (Polysciences Inc., Warrington, PA) containing 0.04% 
nickel chloride and 0.03% hydrogen peroxide (Merck, Darmstadt, 
Germany) for 5 min. Before coverslipping the sections were washed 
under running tap water for 3 min, dehydrated in ethanol series, and 
cleared with xylene. Sections treated with normal rabbit serum 
(1: 1,000) instead of anti-NF or and-SP antibodies were used as 
negative controls. The slides were examined and photographed 
with a Leitz Dialux 22 microscope equipped with a Vario-Ortho-
mat camera. 
Morphometric Evaluation of tbe Stains The NF and SP posi-
dviTies were quantitated using a compurer-assisted image analysis 
system, which consisted of an Olympus BH-2 microscope with a 
color camera attachment (Hitachi Color Camcra FP-3060A, Hita-
chi Denshi, Ldt.) and a Sony Trinitron monitor. Lengths of the 
positive nerves were measured by moving a cursor on a Hipad Digi-
tizer (Bausch & Lomb, Houston Instrument Div.) and simulta-
neously following the trace of the cursor on the image of the sec-
tion. which was projected on the monitor screen. The microscope, 
the monitor, and the digitizer were connected to an IBM Personal 
Computer. 
One representative section on each slide was examined using a 
20x objective. Five adjacent fields were analyzed, which usually 
covered the whole section. Each field consisted of an approximately 
equal area of dermis and epidermis. The lengths of the NF and SP 
positive nerves were measured separately in dermis and epidermis in 
each specimen. 
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Statistics The results in each group STUdied arc expressed as the 
mean ± SEM, and Student's t test has been used in comparison of 
the means. 
RESULTS 
With the staining procedure used in the present study, both NF and 
SP positive fibers could be reproducibly observed in the sk in of the 
three different groups. 
The lengths measured of the NF positive fibers both in dermal 
and epidermal compartments were significantly greater in psoriatic 
lesions (Group 1) than in lesion-free psoriatic (Group 2) or coorral 
(Group 3) skin (Fig 1, Table I). 
No significance was recorded in the dermal SP-positivity be-
Tween different groups. However, the measured epidermal SP-con-
taining nerve fibers summed up significantly higher in psoriatic 
lesions when compared to rhe other groups (Fig 2, Table I). No 
significant differences in any of the measured parameters were ob-
tained between Groups 2 and 3. 
In Group '1, the NF positivity was quite frequently seen in the 
nerve fibers among the dermal inflammatory infiltrate, and in the 
epidermis as well (Fig. la) . In Groups 2 and 3, NF positive fibers 
were observed in the dermis but very rarely in the epidermis (Figs 
Ib,c). 
In Group 1. SP positive nerve fibers were mainly localized in the 
papillary dermis as short thin strands which occasionally extended 
into the epidermis (Fig 2). In Groups 2 and 3, faint SP positivities 
were observed in the dermis, and like NF positivity, very rarely in 
the epidermis. 
DISCUSSION 
Evaluation of cutaneous nerves in a histologic section is quite diffi-
cult because nerve fibers appear randomly and only partially in a 
plane of section. Another difficulty is the relatively small number of 
nerves that can be observed on one section. There are ca. 100 free 
nerve endings per mm2 in a dermal papilla, and only 1-5 in the 
epidermis of human digital skin [t81. Also, fingertips and toes are 
much more densely innervated than other skin areas that were used 
in rhis srudy. Presence of SP-containing nerve fibers has been re-
ported in human skin, but they arc most abundant in fingers and toes 
l8l To overcome these problems in this study relatively thick sec-
tions (16 .um) were cut, and the lengths of rhe stained nerve fibers 
were measured morphometrically. However, sources of error still 
exist, e.g., slight variation in section thickness is possible. and the 
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Figure 1. Sensory nerve fibers (arrows) in the skin. E: epidermis. Anti-neurofll:uncnf antibody (x 450). (a) Psoriatic lesion: A bundle of nerves can be seen in 
the dennis, thin fibers also c:m be seen within the thickened epidennis. (b) Lesion-free psoriatic skin. (r) Control skin. 
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Table I. Lengths of the Positive Nerves (±SEM) and Their 
Significances as Tened against Group 1 
Parameter Group 
NP"<kml" I 
2 
3 
N F" epo<knnu I 
2 
3 
Spb ""milO I 
2 
3 
pb~podt'mi' I 
2 
3 
• NF: ncurofibmCni po5'mYlIy. 
~ SP: substallce P po5'It1YLty. 
C n.s.: not ,igmfiam. 
Length (pm) p< 
833.5 ± 117.8 
344.4 ± 138.0 0.010 
530.3 ± 102.4 0.050 
156.8 ± 40.2 
25.8 ± 13.3 0.025 
29.1 ± 6.9 0.015 
260.6 ± 56.3 
118.4 ± 71.1 n.s." 
146.4 ± 23.6 n.s." 
89.7 ± 16.2 
39.2 ± 8.7 0.035 
10.0±5.1 0.001 
fact that only nerve lengths. not thicknesses, were analyzed. SP is 
rapidly degraded in tissues [19]. and thus the time between removal 
and freezing of the biopsy is critical. It is also practically impossible 
to obtain biopsies from lesions that are at the same stage, which may 
produce variation in the results. Regardless, significant differences 
between the studied groups were found. 
Both the dennis and epidermis in psoriatic lesions were signifi-
candy more densely innervated with NF-positive fibers when com-
pared [Q either lesion-free psoriatic or control skin (Table I). The 
anti-NF antibody stains sensory nerve fibers quite: exclusively as has 
been reported earlier [8,17,20.21]. SP-positivity was scanty in all 
specimens studied. but there was an increase in the total length of 
S~-cont~ining 6b~rs in the psoriatic lesion, the increase being sig-
Ilificant In the epidermal compartment (Table I). Nerve fibers, in-
cluding SP-positive ones, occasionally extended to the free surface 
of the epidermis (Fig 2). A corresponding finding was reported by 
Weddell et 31 [15}, who stained sections from psoriatic lesions with 
tnditional silver stains. Previous studies have revealed no increase in 
SP reactivity in psoriatic skin [22,23]. This could be due to a differ-
ent anti-SP antibody as well as a more sensitive staining system with 
avidin-biotin amplification used in this study. It is possible that the 
~ncreased innervation of the psoriatic lesion is secondary to the 
tnflammatory reaction in the dermis with the more prominent de-
Fig ure 2. A thin substance P positive nerve fi~r (arr0l4ls) , partially visible. 
extends through the epidermiS (E) in a psoriatic lesion. Anti-substance P 
,ntibody (x 900). 
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velopment of dermal papillary blood vessels. In fact, the absence of 
significant alterations in lesion-free skin suggests that there may be a 
link ?crween the development of a psoriatic plaque and the altered 
and tTlcreased number of sensory nerves in the skin. Based on the 
current results, it cannot be determined whether the alteration in 
the nerves precedes the appearance of the lesion or whether it de-
velops at rhe same time along with the other histologic changes. To 
test the specificity of the findings in psoriasis, nerve patterns in 
other inflammatory skin diseases as well as in early psoriatic lesions 
should be studied. Our preliminary studies on lichen ruber planw 
biopsies indicate that the innervation and SP-content in these le-
s~ons resemble those in normal skin (Naukkarinen et ai, in prepara-
non). 
Recently, SP has been shown to increase the severity of arthritis in 
human arthritic joints when injected [24}, and stimulate synovio-
cyte prolifention as well as prostaglandin E2 and collagenase release 
from these cells [25]' Similarly, in psoriatic skin, SP may act as a 
mediator by binding to the receptors on mast cells inducing degran-
ulation [26], which releases numenl mediators of inflammation 
[27]. The increased numher of mast cells (14] and sensory nerve 
fibers (Fig la, Table I) provides an excellent microenvironment for 
the rapid amplification of neuro~enic inflammation through the 
axon reflex in the psoriatic lesion 15,10]. In this study, the measured 
SP-positivity was significantly increased in the epidermis of the 
psoriatic lesion only (Table 1). However. SP is not the only neuro-
peptide detected in the sensory nerve fibers. Coexistence of SP and 
calcitonin . gene-~e1ate~ peptide (C.GRP) .in t~ese nerves has been 
observed m rat mtcsune 128}, gUlIlea pig skill [29}. and also in 
human digital skin [8]. Because the psoriatic lesion is densely inner-
vated with sensory fibers, it is possible that other neuropeptides 
besides SP are contributing to the inllammatory reaction in the 
lesion [5J. CGRP and neurokinin A have been ,J:resented as candi-
dates for mediating neurogenic inflammation 130]. Both of these 
peptides have characteristics in common with SP. All of them are 
potent vasodilators and become depleted from the sensory nerves by 
capsaicin [30]. which has ""en used to treat psoriasis [31]. 
The potency of SP to influence immunocompetent cells such as 
macrophages and T lymphocytes, which produce numerous media-
tors of inflammation, could account for the inflammatory reaction 
in the psoriatic papillary deTlnis [32-34]. This suggestion is sup-
ported by the observation that strands of SP-rositive nerves were 
detected in the epidermis and in the papillae 0 the psoriatic lesions 
surrounded by inflammatory cells. It must be pointed out, however, 
that with the immunohistochemical techniques used in this study, it 
is impossible to know if SP is present in the psoriatic lesions in 
biologically active amounts. SP is difficult to detect because it is 
easily degraded in tissues (19]. A study hy Wallengren ct al describes 
elevated SP concentrations in suction blister fluid of psoriasis as 
compared to healthy controls as well as certain other inflammatory 
dermatoses [35J. 
This study shows that sensory nerve fibers arc significantly in-
creased in the psoriatic lesion as compared to lesion-free psoriatic or 
control skin. SP-content, although scanty and not measured per se, 
was significantly greater in the epidermal nerve fibers of the psoria-
tic le"ion . These 6ndings suggest" thar SP. or other nC'uropeptides in 
sensory nerves, may be an important mediator in the inflammatory 
processes associated with the psoriatic lesion. 
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